首页> 外文OA文献 >Developing a vaccination evaluation model to support evidence-based decision making on national immunization programs.
【2h】

Developing a vaccination evaluation model to support evidence-based decision making on national immunization programs.

机译:开发疫苗接种评估模型,以支持基于证据的国家免疫规划决策。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Among all public health provisions national immunization programs (NIPs) are beyond doubt one of the most effective in reducing mortality, morbidity, and costs associated with major infectious diseases. To maintain their success, NIPs have to modernize in response to many new and old demands regarding efficacy, safety, availability of new vaccines, emerging and evolving pathogens, waning immunity, altered epidemiological situations, and the public's trust in the program. In this paper we present an evaluation model in the form of a checklist that may help in collecting relevant scientific information that is necessary for evaluation and decision making when considering changes in a NIP. Such a checklist points to relevant information on the vaccine-preventable disease, the pathogen causing it, the vaccine, and the cost-effectiveness ratio of the vaccine. However, the final judgment on a potential change in the NIP cannot be based on a simple algorithm, as the relevant information reflects factors of a very different kind and magnitude, to which different value judgements may be added, and which may have certain degrees of uncertainty. Because any change in the NIP may be accompanied by more or less unforeseen changes in the vaccine's efficacy, evolutionary consequences, including the antigenic composition of the pathogen, and the vaccine's safety profile, an intensive surveillance program should accompany any NIP. Elements thereof include clinical-epidemiological surveillance, surveillance of vaccination coverage, immune surveillance, surveillance of microbial population dynamics, and surveillance of adverse events and safety issues. We emphasize that the decision to introduce a vaccine in the NIP should be taken as seriously, both scientifically and ethically, as the decision to withhold a vaccine from the NIP. In the latter case one might be responsible for vaccine-preventable disease and mortality.
机译:在所有公共卫生规定中,毫无疑问,国家免疫计划(NIP)是最有效的降低主要传染病相关死亡率,发病率和成本的方法之一。为了保持其成功,国家实施计划必须现代化,以应对有关功效,安全性,新疫苗的可用性,病原体的出现和发展,免疫力下降,流行病学状况改变以及公众对该计划的信任等许多新旧要求。在本文中,我们以清单的形式提出了一种评估模型,该模型可以帮助收集有关NIP变更时进行评估和决策所必需的相关科学信息。这样的清单指向有关疫苗可预防的疾病,引起该病的病原体,疫苗以及疫苗的成本效益比的相关信息。但是,关于NIP潜在变化的最终判断不能基于简单的算法,因为相关信息反映的是种类和大小非常不同的因素,可以在其中添加不同的值判断,并且可能具有一定程度的影响。不确定。由于NIP的任何变化都可能伴随或多或少发生疫苗功效,进化后果(包括病原体的抗原成分)和疫苗的安全性等不可预见的变化,因此,任何NIP都应进行严格的监控程序。其要素包括临床流行病学监测,疫苗接种覆盖率监测,免疫监测,微生物种群动态监测以及不良事件和安全问题的监测。我们强调,在科学和道德上应认真考虑在国家实施计划中引入疫苗的决定,与从国家实施计划中保留疫苗的决定一样。在后一种情况下,可能是疫苗可预防的疾病和死亡率的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号